Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecular and Cellular Biology

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.01950-05PMID 16914727PMCID PMC1592831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ERBB receptors and cancer: the complexity of targeted inhibitors

  2005cited by this paper
• ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors

  2005cited by this paper
• Presenilin-dependent γ-Secretase Processing Regulates Multiple ERBB4/HER4 Activities*

  2005cited by this paper
• Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma

  2005cited by this paper
• Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells.

  2005cited by this paper
• Secretase-dependent Tyrosine Phosphorylation of Mdm2 by the ErbB-4 Intracellular Domain Fragment*

  2005cited by this paper
• Coexpression of the type 1 growth factor receptor family members HER‐1, HER‐2, and HER‐3 has a synergistic negative prognostic effect on breast carcinoma survival

  2005cited by this paper
• Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.

  2005cited by this paper
• Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level.

  2004cited by this paper
• Regulation of Mouse Mammary Gland Development and Tumorigenesis by the ERBB Signaling Network

  2004cited by this paper
• The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone

  2004cited by this paper
• ErbB receptors: directing key signaling networks throughout life.

  2004cited by this paper
• Brca1-Deficient Murine Mammary Epithelial Cells have Increased Sensitivity to CDDP and MMS

  2004cited by this paper
• A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.

  2004cited by this paper
• Genetic Pathways to Glioblastoma

  2004cited by this paper
• Outcome and human epidermal growth factor receptor (HER) 1–4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

  2004cited by this paper
• Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

  2004cited by this paper
• Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality

  2003cited by this paper
• Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.

  2003cited by this paper
• Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer

  2003cited by this paper
• ErbBs in mammary development.

  2003cited by this paper
• The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

  2003cited by this paper
• Cyclin B1 and CDK1: nuclear localization and upstream regulators.

  2003cited by this paper
• Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5

  2003cited by this paper
• WW Domain-containing Protein YAP Associates with ErbB-4 and Acts as a Co-transcriptional Activator for the Carboxyl-terminal Fragment of ErbB-4 That Translocates to the Nucleus*

  2003cited by this paper
• EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).

  2003cited by this paper
• The Expression of EGFR Family Ligands in Breast Carcinomas

  2002cited by this paper
• Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer

  2002cited by this paper
• EGFR family expression in breast carcinomas. c‐erbB‐2 and c‐erbB‐4 receptors have different effects on survival

  2002cited by this paper
• CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.

  2002cited by this paper
• HER2/neu as a predictive factor in breast cancer.

  2001cited by this paper
• Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice

  2001cited by this paper
• The Role of c-erbB-2/HER2/neu in Breast Cancer Progression and Metastasis

  2001cited by this paper
• Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer Cells

  2001influential reference
• γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase

  2001cited by this paper
• Lessons learned from BRCA1 and BRCA2

  2000cited by this paper
• Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers.

  2000cited by this paper
• Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay.

  2000cited by this paper
• The ErbB signaling network: receptor heterodimerization in development and cancer

  2000cited by this paper
• Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.

  1999cited by this paper
• Erbb4 Signaling in the Mammary Gland Is Required for Lobuloalveolar Development and Stat5 Activation during Lactation

  1999cited by this paper
• Heregulin Induces Phosphorylation of BRCA1 through Phosphatidylinositol 3-Kinase/AKT in Breast Cancer Cells*

  1999cited by this paper
• Expression of c-erbB3 protein in primary breast carcinomas.

  1998cited by this paper
• Specificity within the EGF family/ErbB receptor family signaling network

  1998cited by this paper
• Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer.

  1998cited by this paper
• c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer

  1998cited by this paper
• Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland.

  1998cited by this paper
• c-erbB-3 protein expression in ductal carcinoma in situ of the breast.

  1997cited by this paper
• BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

  1997cited by this paper
• Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.

  1996cited by this paper
• BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

  1996cited by this paper
• BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

  1996cited by this paper
• Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells.

  1996cited by this paper
• The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.

  1995cited by this paper
• c‐erbB‐3 protein expression in human breast cancer: comparison with other tumour variables and survival

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper

• Anticancer Potential of 1,2,3-triazole-Tethered Isonicotinate Hybrids: Synthesis, In-silico Studies, In-vitro Studies and MD Simulation

  2025cites this paper
• Portrait of WWP1: the current state in human cancer

  2025cites this paper
• Overexpressed nicotinamide N‑methyltransferase in endometrial stromal cells induced by macrophages and estradiol contributes to cell proliferation in endometriosis

  2024cites this paper
• Structure-Based In Silico Investigation of Agonists for Proteins Involved in Breast Cancer

  2022cites this paper
• "Shedding" light on HER4 signaling in normal and malignant breast tissues.

  2022cites this paper
• The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein

  2022cites this paper
• A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors

  2021cites this paper
• WW Domain-Containing E3 Ubiquitin Protein Ligase 1: A Self-Disciplined Oncoprotein

  2021cites this paper
• Expression and Prognosis of HER Family in Breast Cancer

  2021cites this paper
• Salidroside Ameliorates Mitochondria-Dependent Neuronal Apoptosis after Spinal Cord Ischemia-Reperfusion Injury Partially through Inhibiting Oxidative Stress and Promoting Mitophagy

  2020cites this paper
• Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficking

  2020cites this paper
• The role of ErbB4 in cancer

  2020influential citation
• Biasing HER4 Tyrosine Kinase Signaling with Antibodies: Induction of Cell Death by Antibody-Dependent HER4 Intracellular Domain Trafficking

  2019cites this paper
• The protective effect of betacellulin against acute pancreatitis is ERBB4 dependent

  2019cites this paper
• GPCR kinase 2–interacting protein‐1 protects against ischemia‐reperfusion injury of the spinal cord by modulating ASK1/JNK/p38 signaling

  2018cites this paper
• Change in Topoisomerase 1–Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol

  2018cites this paper
• Sex differences in NSAID‐induced perturbation of human intestinal barrier function and microbiota

  2018cites this paper
• A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer

  2017cites this paper
• Human epidermal growth factor receptor 4 (HER4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis

  2016cites this paper
• Development of an ErbB4 monoclonal antibody that blocks neuregulin-1-induced ErbB4 activation in cancer cells.

  2016cites this paper
• Association between ERBB4 gene polymorphism in the microRNA binding site and endometrial carcinoma risk

  2015cites this paper
• Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis

  2014cites this paper
• Nuclear ErbB4 signaling through H3K9me3 is antagonized by EGFR-activated c-Src

  2013cites this paper
• ErbB2 Dephosphorylation and Anti-Proliferative Effects of Neuregulin-1 in ErbB2-Overexpressing Cells; Re-evaluation of Their Low-Affinity Interaction

  2013cites this paper
• Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.

  2013cites this paper
• Epidermal growth factor receptor (EGFR) family members are dysregulated in a number of epithelial cell malignancies, including breast cancer[1]. The first three members of the family: EGFR/HER1, HER2 and HER3 promote oncogenic transformation, more proliferative and aggressive

  2012cites this paper
• DNA损伤修复与肺癌顺铂耐药机制的研究进展

  2011cites this paper
• Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy

  2011cites this paper
• EGF and TGF-β1 Effects on Thyroid Function

  2011cites this paper
• HER4 Cyt1 and Cyt2 Isoforms Regulate Transcription Through Differential Interactions with a Transcriptional Regulator, Yap

  2011cites this paper
• Potential of ErbB4 antibodies for cancer therapy.

  2010cites this paper
• Betacellulin protects from pancreatitis by activating stress-activated protein kinase.

  2010cites this paper
• Cell Death or Survival Promoted by Alternative Isoforms of ErbB4

  2010cites this paper
• Role of ErbB2 and ErbB4 in Cancer Growth, Prognosis and as Targets for Immunotherapy

  2010cites this paper
• Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells

  2010cites this paper
• Re-epithelialization from human skin explant cultures is promoted by ligand-activated HER3 receptor.

  2010cites this paper
• The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene

  2009cites this paper
• ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo

  2009cites this paper
• WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer

  2009influential citation
• ErbB4/HER4: Role in Mammary Gland Development, Differentiation and Growth Inhibition

  2008cites this paper
• Role of ErbB4 in Breast Cancer

  2008cites this paper
• The E3 Ubiquitin Ligase WWP1 Selectively Targets HER4 and Its Proteolytically Derived Signaling Isoforms for Degradation

  2008influential citation
• The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.

  2007cites this paper
• Role of heregulin in human cancer

  2007cites this paper
• HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4.

  2007influential citation
• Breast cancer: the upgraded role of HER-3 and HER-4.

  2007cites this paper
• HER 4 D-Box Sequences Regulate Mitotic Progression and Degradation of the Nuclear HER 4 Cleavage Product s 80 HER 4

  2007cites this paper
• ErbB receptors: new insights on mechanisms and biology.

  2006cites this paper
• Genetic Pathways to Glioblastoma

  2004cites this paper